Cabozantinib Plus Nivolumab as First‑Line Therapy for Advanced Renal Cell Carcinoma With Bone Metastases: A Clinical Case Report

About the Patient This case features AK, a 58-year-old female who was initially diagnosed with stage IB clear cell renal cell carcinoma (RCC) in 2018, for […]